Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 18 Feb 2026 for Boston Scientific CORP.
Filing timeline
BuySaleVance R. Brown
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
Vance R. Brown: trading record in brief
Vance R. Brown, SVP, GC and Corp. Secretary at Boston Scientific Corp, has filed 71 filings between October 4, 2021 and February 18, 2026. The record holds only equity-pay filings and sales: 33 grants, 31 option exercises, 7 sales, no purchase.
The 7 sales come to EUR 4,827,768, with a median of EUR 480,920. The two largest are one day apart: EUR 1,256,173 on May 21, 2024 and EUR 1,053,658 on May 22, 2024; the third, EUR 736,870, dates from August 25, 2023.
2025 is the busiest year, with 18 filings, ahead of 2022 and 2024 (14 each) and 2023 (13). Ten filings fall in the last twelve months, none of them a purchase or a sale. The median publication delay is 2 days.
Within 30 days of colleagues at Boston Scientific, Brown's own market trades count 6 with Arthur C. Butcher, 6 with John Bradley Sorenson, 5 with Jeffrey B. Mirviss, 4 with Daniel J. Brennan and 4 with Edward J. Ludwig, all on the same side.
Companies and markets linked to Vance R. Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations71 total
14,804 shares0Common StockSEC:0001225208-26-002132:1
1,118 shares0Common StockSEC:0001225208-26-002132:2
1,851 shares0Common StockSEC:0001225208-26-002132:4
1,839 shares0Common StockSEC:0001225208-26-002132:6
12,792 shares@ US$74.739.6% of flowCommon StockSEC:0001225208-26-002132:3
895 shares@ US$74.730.7% of flowCommon StockSEC:0001225208-26-002132:5
890 shares@ US$74.730.7% of flowCommon StockSEC:0001225208-26-002132:7
14,804 shares0Common StockSEC:0001225208-26-002132:0
488 shares@ US$74.120.4% of flowCommon StockSEC:0001225208-26-002013:1
1,442 shares0Common StockSEC:0001225208-26-002013:0
1,952 shares@ US$104.782.1% of flowCommon StockSEC:0001225208-25-006330:1
4,036 shares0Common StockSEC:0001225208-25-006330:0
4,826 shares@ US$106.4215.5% of flowCommon StockSEC:0001225208-25-005376:0
4,826 shares@ US$95.0913.6% of flowCommon StockSEC:0001225208-25-004327:0
4,826 shares@ US$100.8515.3% of flowCommon StockSEC:0001225208-25-003606:0
4,826 shares@ US$104.6416.4% of flowCommon StockSEC:0001225208-25-002170:0
1,839 shares0Common StockSEC:0001225208-25-001864:2
1,000 shares0Common StockSEC:0001225208-25-001864:4
895 shares@ US$106.111.1% of flowCommon StockSEC:0001225208-25-001864:1
890 shares@ US$106.111.1% of flowCommon StockSEC:0001225208-25-001864:3
484 shares@ US$106.110.6% of flowCommon StockSEC:0001225208-25-001864:5
1,850 shares0Common StockSEC:0001225208-25-001864:0
424 shares@ US$105.770.5% of flowCommon StockSEC:0001225208-25-001789:1
1,442 shares0Common StockSEC:0001225208-25-001789:0
6,350 shares@ US$105.987.8% of flowCommon StockSEC:0001225208-25-001680:1
25 of 71 declarations
